The prevalence of AIS, ICH, and total stroke was not significantly different in ITP patients treated with TPO-RAs when compared to ITP patients not treated with TPO-RAs (p = 0.88, p = 0.79, and p = 0.37, respectively). Here, TPO is linked to autoimmune thrombocytopenic purpura.